SCHEMBL6172473

SCHEMBL6172473

CC1(Cc2ccncc2NS(N)(=O)=O)NC(=O)N(c2ccc(SC(F)(F)F)cc2)C1=O

nearest known ligand 0.42

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 17/20 0.42
NTRK1 P04629 1/20 0.34
AR P10275 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172456 0.90 IGF1R (0.42) IGF1RNTRK1AR
SCHEMBL6173351 0.90 IGF1R (0.41) IGF1RNTRK1AR
SCHEMBL6176637 0.88 IGF1R (0.40) IGF1RNTRK1ALDH1A1
SCHEMBL6175453 0.88 IGF1R (0.40) IGF1RNTRK1
SCHEMBL6177613 0.87 IGF1R (0.41) IGF1R
SCHEMBL6174113 0.87 IGF1R (0.40) IGF1RARALDH1A1
SCHEMBL6172038 0.86 IGF1R (0.41) IGF1RNTRK1
SCHEMBL6173987 0.86 IGF1R (0.45) IGF1RNTRK1
SCHEMBL6172542 0.85 IGF1R (0.38) IGF1RNTRK1
SCHEMBL6172562 0.84 IGF1R (0.47) IGF1RAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed